NVS SG&A Expenses
Novartis AG Common Stock · SG&A Expenses
NVS SG&A Expenses
Latest reported$13.13Bperiod ending
NVS SG&A Expenses ($7.87B → $13.13B)
Annual SG&A Expenses
High-resolution chart · PNG
NVS sg&a expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 13,305,790,000 | |
| 12,566,000,000 | |
| 12,517,000,000 | |
| 12,193,000,000 | |
| 12,827,000,000 | |
| 14,197,000,000 | |
| 14,369,000,000 | |
| 13,717,000,000 | |
| 12,465,000,000 | |
| 14,192,000,000 | |
| 14,247,000,000 | |
| 14,993,000,000 | |
| 15,241,000,000 | |
| 15,117,000,000 | |
| 18,049,000,000 | |
| 15,797,000,000 | |
| 14,331,000,000 | |
| 14,097,000,000 | |
| 13,259,000,000 | |
| 11,974,000,000 | |
| 10,633,000,000 | |
| 9,989,000,000 | |
| 9,235,000,000 | |
| 7,883,000,000 | |
| 7,165,000,000 | |
| 8,069,000,000 | |
| 6,941,000,000 | |
| 7,866,279,000 |